Abstract
Background
Ibuprofen and acetaminophen are the most widely used antipyretic agents in pediatric practice. Despite their common use, comparative evidence on their relative efficacy in febrile children remains heterogeneous, and clinical recommendations vary across guidelines and countries.
Objective
We aimed to evaluate the comparative antipyretic efficacy of ibuprofen versus acetaminophen in febrile children through a systematic review and meta-analysis restricted to randomized controlled trials.
Methods
A systematic search was conducted in Scopus, PubMed, and Web of Science using a predefined strategy combining terms for ibuprofen, paracetamol/acetaminophen, fever/febrile/pyrexia, and pediatric populations. The primary outcome was the proportion of children afebrile at 4 h. Continuous outcomes included temperature reduction at 4 h, time without fever during the first 4 h, and time-weighted summary temperature differences over 0–8 h. The study protocol was registered in PROSPERO (CRD420261353471).
Results
A total of 479 records were identified; after duplicate removal and screening, seven studies were included in the quantitative synthesis. For the primary outcome of afebrile status at 4 h, the pooled risk ratio was 1.26 (95% confidence interval [CI] 0.88–1.80; p = 0.106). Temperature reduction at 4 h was significantly greater with ibuprofen (mean difference 0.31 °C, p = 0.024). The time-weighted summary temperature outcome over 0–8 h numerically favored ibuprofen but did not reach statistical significance (mean difference − 3.52, 95% CI − 21.24 to 14.21; p = 0.240; I2 = 57.6%). An exploratory standardized mean difference analysis across heterogeneous continuous outcomes (seven comparisons) yielded a near-null pooled effect (Hedges’ g − 0.08, 95% CI − 0.40 to 0.25; p = 0.645; I2 = 84.0%).
Conclusions
The primary outcome—the proportion of children achieving afebrile status at 4 h—did not differ significantly between ibuprofen and acetaminophen (risk ratio 1.26, 95% CI 0.88–1.80; p = 0.106). Ibuprofen produced a statistically greater reduction in temperature at 4 h compared with acetaminophen (mean difference 0.31 °C), although this difference is unlikely to be clinically meaningful. These findings suggest a marginal quantitative advantage of ibuprofen to decrease body temperature, without a clinically significant difference between the two agents.
Access this article
Subscribe and save
- Starting from 10 chapters or articles per month
- Access and download chapters and articles from more than 300k books and 2,500 journals
- Cancel anytime
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
References
Moon S-Y, Lim KR, Son JS. The role of infectious disease consultations in the management of patients with fever in a long-term care facility. PLoS ONE. 2023;18(9):e0291421.
Paul IM, Walson PD. Acetaminophen and ibuprofen in the treatment of pediatric fever: a narrative review. Curr Med Res Opin. 2021;37(8):1363–75.
Cendejas-Hernandez J, Sarafian JT, Lawton VG, Palkar A, Anderson LG, Lariviere V, et al. Paracetamol (acetaminophen) use in infants and children was never shown to be safe for neurodevelopment: a systematic review with citation tracking. Eur J Pediatr. 2022;181(5):1835–57.
de’Angelis GL, Vincenzi F, Fornaroli F, Buonvicino D, Chiarugi A. New perspectives for optimizing fever and pain management in pediatrics: evidence supporting therapeutic awareness in clinical practice. Ital J Pediatr. 2025;51(1):255.
Tan E, Braithwaite I, McKinlay CJD, Dalziel SR. Comparison of acetaminophen (paracetamol) with ibuprofen for treatment of fever or pain in children younger than 2 years: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(10):e2022398.
Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009;25(9):2207–22.
Sjoukes A, Venekamp RP, van de Pol AC, Hay AD, Little P, Schilder AG, et al. Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children. Cochrane Database Syst Rev. 2016;12(12):CD011534.
Luo S, Ran M, Luo Q, Shu M, Guo Q, Zhu Y, et al. Alternating acetaminophen and ibuprofen versus monotherapies in improvements of distress and reducing refractory fever in febrile children: a randomized controlled trial. Paediatr Drugs. 2017;19(5):479–86.
Sterne JAC, et al. RoB 2: a revised tool for assessing risk of bias in randomised trial. BMJ. 2019;366:l4898.
Sterne JAC, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275–342.
Ayoub SS. Paracetamol (acetaminophen): a familiar drug with an unexplained mechanism of action. Temperature. 2021;8(4):351–71.
Aleman M. “The good, the bad and the ugly’: interplay of innate immunity and inflammation. Cell Microbiol. 2022. https://doi.org/10.1155/2022/2759513.
Van Esch A, Van Steensel-Moll HA, Steyerberg EW, Offringa M, Habbema JDF, Derksen-Lubsen G. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 1995;149(6):632–7.
Autret E, Reboul-Marty J, Henry-Launois B, Laborde C, Courcier S, Goehrs JM, et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol. 1997;51:367–71.
Hay AD, Costelloe C, Redmond NM, Montgomery AA, Fletcher M, Hollinghurst S, et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008;337:a1302.
McIntyre J, Hull D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. Arch Dis Child. 1996;74:164–7.
Jayawardena S, Kellstein D. Antipyretic efficacy and safety of ibuprofen versus acetaminophen suspension in febrile children: results of 2 randomized, double-blind, single-dose studies. Clin Pediatr (Phila). 2017;56(12):1120–7.
Alaje EO, Udoh EE, Akande PA, Odey FA, Meremikwu MM. Ibuprofen versus paracetamol for treating fever in preschool children in Nigeria: a randomized clinical trial of effectiveness and safety. Pan Afr Med J. 2020;36:350.
Erlewyn-Lajeunesse MDS, Coppens K, Hunt LP, et al. Randomised controlled trial of combined paracetamol and ibuprofen for fever. Arch Dis Child. 2006;91(5):414–6.
Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011;127(3):580–7.
Wrotek S, Sobocinska J, Kozlowski HM, Pawilikowska M, Jedrzejewski T, Dzialuk A. New insights into the role of glutathione in the mechanism of fever. Int J Mol Sci. 2020;21(4):1393.
Kozer E, Evans S, Barr J, Greenberg R, Sorianio I, Bulkowstein M, et al. Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high-dose paracetamol. Br J Clin Pharmacol. 2003;55(3):234–40.
Burlacu R, Bourdin V, Blin P, Camaioni F, Clairaz B, Lantéri-Minet M, et al. Anti-inflammatoires non stéroïdiens en prescription médicale facultative: mise au point dans la prise en charge de la douleur aiguë. Therapies. 2025;80:449–68.
Tan E, McKinlay CJD, Riley J, Rao M, Mravicich L, Lawrence S, et al. Paracetamol versus ibuprofen as required for fever or pain in the first year of life and the risk of eczema and bronchiolitis at age 1 year in New Zealand (PIPPA Tamariki): a multicentre, open-label, parallel-group, superiority, randomised controlled trial. Lancet Child Adolesc Health. 2026;10(3):156–66.
Funding
No external funding was received for the conduct of this study or the preparation of this article.
Ethics declarations
Conflict of Interest
Gian Luigi Marseglia, Paola Giovanna Marchisio, Gregorio Paolo Milani, Michele Miraglia del Giudice, Irene Schiavetti, and Giorgio Ciprandi have no conflicts of interest that are directly relevant to the content of this article.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Ethical Approval
Not applicable. This study is a systematic review and meta-analysis of published data and did not involve human participants directly.
Availability of Data and Material
All data used in this meta-analysis are available from the original published trial reports cited in the reference list.
Code Availability
Not applicable.
Author Contributions
GLM: conceptualization, supervision, manuscript review. PGM: conceptualization, manuscript review. GPM: data extraction, manuscript review. MMdG: data extraction, manuscript review. IS: statistical analysis, methodology. GC: conceptualization, literature search, writing (original draft), writing (review and editing). All authors have read and approved the final version of the manuscript.
AI Use
AI was used for refining the language.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Marseglia, G.L., Marchisio, P.G., Milani, G.P. et al. Efficacy of Ibuprofen Versus Acetaminophen for Acute Fever Management in Febrile Children: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Pediatr Drugs (2026). https://doi.org/10.1007/s40272-026-00773-2
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1007/s40272-026-00773-2